Female Sexual Dysfunction: Therapeutic Options and Experimental Challenges

Author(s): Kyan J. Allahdadi , Rita C.A. Tostes , R. Clinton Webb .

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry

Volume 7 , Issue 4 , 2009

Become EABM
Become Reviewer

Abstract:

Female sexual dysfunction (FSD) is a prevalent problem, afflicting approximately 40% of women and there are few treatment options. FSD is more typical as women age and is a progressive and widespread condition. Common symptoms associated with FSD include diminished vaginal lubrication, pain and discomfort upon intercourse, decreased sense of arousal and difficulty in achieving orgasm. Only a small percentage of women seek medical attention. In comparison to the overwhelming research and treatment for erectile dysfunction in males, specifically with the development of phosphodiesterase type 5 inhibitors, significantly less has been explored regarding FSD and treatment is primarily limited to psychological therapy. Several cardiovascular diseases have been linked with FSD including atherosclerosis, peripheral arterial disease and hypertension, all of which are also pathological conditions associated with aging and erectile dysfunction in men. Using animal models, we have expanded our understanding of FSD, however a tremendous amount is still to be learned in order to properly treat women suffering from FSD. The aim of this review is to provide the most current knowledge on FSD, advances in basic science addressing this dysfunction, and explore developing therapeutic options.

Keywords: Female sexual dysfunction, pudendal arteries, clitoris, vagina

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 4
Year: 2009
Page: [260 - 269]
Pages: 10
DOI: 10.2174/187152509789541882
Price: $58

Article Metrics

PDF: 6